spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Pharmaceutical Microbiology East Coast

SMI - Pharmaceutical Microbiology East Coast

13-14 November 2017
Renaissance Woodbridge Hotel, New Jersey

Drawing on from the huge success of SMi’s Pharmaceutical Microbiology event series, SMi is delighted to announce the launch of Pharmaceutical Microbiology East Coast. Being the eighth in its series, this event will take place in New Jersey, USA, on November 13th and 14th 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology East Coast 2017 will address the best practices for rapid microbial and sterility testing and tackle the challenges of contamination control.

Pharmaceutical Microbiology East Coast has been produced with a vision of promoting the field of microbiology, and has been tailored to address the current issues and opportunities the industry faces every day. Topics of interest will include:
• The role of microbiology in pharmaceutical stability programs
• Deciphering the host-microbe interaction
• Benefits of real-time monitoring of airborne viable microorganisms
• Current expectations for a complete environmental monitoring program
• Quality control strategy on low endotoxin recovery (LER)
• Implementation of a global electronic intervention logging system
Chair for 2017:
• Jeanne Moldenhauer, Vice President, Excellent Pharma Consultant
Expert Speaker Line-Up Includes:
• Andrew Bartko, Research Leader, Battelle Memorial Institute
• Brian Hubka, CEO, BGH Internationalv
• Shawn Sweeney, Senior Process Development Manager, Charles River
• Frederic Ayers, Consultant Scientist, Sterility Assurance, Eli Lilly And Company
• Geeta Singh, Pilot Plant Technical Specialist III, Genentech
• Somduttan Saha, Post-Doctoral Scientist, Glaxosmithkline
• Shahram Lavasani, CEO, ImmuneBiotech AB
• James Hauschild, Principal Scientist, Johnson & Johnson
• Tony Cundell, Principal Consultant, Microbiological Consulting, LLC
• David Huang, Chief Medical Officer, Motif BioSciences
• Tony Van Hoose, Director, Sterile Technologies Expertise, Sanofi
• Jim Polarine, Senior Technical Service Manager, STERIS Corporation
• Joseph Chen, Executive Director, CMC Quality Control, Ultragenyx Pharmaceutical
Exclusive highlights in 2017:

• Discuss training of media fill inspection operators with Sanofi
• Decipher the Host-Microbe interaction with GlaxoSmithKline
• Hear Eli Lilly’s keynote address on Implementation of a global electronic intervention logging system
• Understand the role of microbiology in pharmaceutical stability programs with Microbiological Consulting, LLC
• Delve into the current expectations for a complete environmental monitoring program with Excellent Pharma Consulting
Other event highlights include TWO exclusive post-conference interactive workshops carefully selected to enhance your conference experience and encourage personal and professional development. Places are strictly limited to ensure optimal learning for attendees.

Workshop A – Navigating the requirements of a modern QC Microbiology Laboratory
Wednesday 15th November 2017 | 08.30 – 12.30
Workshop Leaders: Quality Executive Partners, Inc.

Workshop B – Contamination Control in Cleanrooms
Wednesday 15th November 2017 | 13.30 – 17.30
Workshop Leader: STERIS Corporation
phone Tel: +44 (0) 207 827 6012
email kwilliams@smi-online.co.uk
web bit.ly/2snC3tc
email New Jersey, USA
 
Print this page
Send to a friend
   
spacer
Industry Events

ASPIRE: International EDGE Conference

28 February - 1 March 2018, The Vox Conference Centre, Birmingham

The ASPIRE international conference is taking place on the 28th February and 1st March 2018 at the Vox Conference Centre in Birmingham. The conference brings together members of the research community including research professionals from the NHS, Clinical Trial Networks and international organisations. The ASPIRE conference will allow delegates to share knowledge and best practise with the focus on enhancing the efficiency and productivity of clinical research across the UK and beyond.
More info >>

White Papers

Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test

Wickham Laboratories Limited

Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >>


News and Press Releases

Ludger appoints Paul Plume as Chief Operating Officer

Ludger Ltd, providing world-leading glycobiology expertise, glycotechnology products and services, is delighted to announce the appointment of Paul Plume as Chief Operating Officer
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement